PharmaCyte Biotech, Inc.
PMCB
$1.13
$0.188920.07%
NASDAQ
| 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -7.27% | -19.60% | -36.14% | -34.96% | -18.02% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 7.91% | -57.95% | 105.33% | -7.54% | -12.76% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 31.90% | -20.48% | -35.11% | -34.82% | -17.99% |
|
|
|||||
| Total Current Assets | 31.90% | -20.48% | -35.11% | -34.82% | -17.99% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 0.00% | 0.00% | 0.00% | 0.00% | -56.35% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 31.17% | -9.17% | 10.69% | -15.98% | 67.34% |
| Total Assets | 25.87% | -20.45% | -21.51% | 17.18% | -16.05% |
|
|
|||||
| Total Accounts Payable | -17.67% | 39.10% | -37.08% | 42.27% | -19.58% |
| Total Accrued Expenses | -26.54% | 0.31% | 3.38% | -6.95% | -5.06% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -40.33% | -0.98% | 535.39% |
| Total Other Current Liabilities | -- | -- | -40.33% | -0.98% | 535.39% |
| Total Current Liabilities | 144.00% | -74.99% | -36.09% | 0.70% | 229.88% |
|
|
|||||
| Total Current Liabilities | 144.00% | -74.99% | -36.09% | 0.70% | 229.88% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -84.77% | -65.30% | -29.02% | -25.35% | -13.12% |
| Total Liabilities | -8.41% | -69.28% | -32.10% | -15.87% | 18.70% |
|
|
|||||
| Common Stock & APIC | 0.04% | 0.04% | -0.75% | -1.41% | -2.05% |
| Retained Earnings | 12.15% | -3.25% | -1.59% | 20.26% | 1.15% |
| Treasury Stock & Other | -0.39% | -0.52% | -3.31% | -1.78% | -2.90% |
| Total Common Equity | 28.92% | -7.37% | -8.92% | 72.56% | -11.88% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -55.06% | -32.26% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -55.06% | -47.97% |
|
|
|||||
| Total Common Equity | 28.92% | -7.37% | -8.92% | 72.56% | -11.88% |
| Total Preferred Equity | -- | -- | -- | -55.06% | -47.97% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 28.92% | -7.37% | -18.08% | 34.23% | -27.07% |
|
|
|||||